Announced Wed, 24 Jun · 18:21 IST
Goldline Pharma Confirms It's Not a Large Corporate Under SEBI Norms
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.2%1-day move
₹44.93
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.2-4.6-5.9-6.0-6.3-8.1-9.3-14.6——
Up moveDown movePending
AI summary
Goldline Pharmaceutical Ltd has filed an initial disclosure confirming it is not classified as a Large Corporate under SEBI's framework. The company reported outstanding borrowings of Rs 9.16 crore as on 31 March 2026, which falls below the threshold required for Large Corporate status. Credit rating and fine-payment stock exchange fields are marked Not Applicable. This is a routine annual compliance filing under SEBI circulars dated November 2018 and October 2023.
Likely market impact
Routine compliance filing with no material impact on shareholders or stock. Confirms small borrowings base of Rs 9.16 crore.